天冬钾镁是国外七十年代新发展的一种心血管疾病药物。我厂在南京药学院等单位协作下,经过两年多的努力,已试制天冬钾镁注射液成功。通过小试、中试和扩大试产,证明生产工艺成熟,产品质量稳定,并经省市药检部门复验合格。为了证明产品结构,又单独制成 L-天冬氨酸钾盐和 L-天冬氨酸镁盐的结晶。经江苏省化工研究所用质谱、核磁共振、红外扫描等方法,将单体结晶、本品与匈牙利商品“脉安定”(panangin)作 Aspartame potassium magnesium is a newly developed foreign seventies a cardiovascular disease drugs. I plant in Nanjing Pharmaceutical College and other units in collaboration, after more than two years of efforts, trial of Aspartame potassium magnesium injection success. Through small test, pilot test and extended trial production, the production process is proved to be mature, the product quality is stable, and passed the reinspection by provincial and municipal drug testing departments. In order to prove the product structure, crystals of L-aspartic acid potassium salt and L-aspartic acid magnesium salt were separately prepared. The Institute of Chemical Industry in Jiangsu Province by mass spectrometry, nuclear magnetic resonance, infrared scanning and other methods, the monomer crystallization, the goods and the Hungarian goods “pulse stability” (panangin) for